Issues our people solve.
Immuno-oncology has solidified its position as the most exciting advancement in cancer treatment in recent times providing hope for long-term survival for those with terminal disease. These exciting new treatments change the treatment paradigm and increase survival rates. This impacts service throughput and clinic time by increasing the number of patients in the system which … Continued
Entering a crowded established market with a price premium? Our clients come to us with some of their most insurmountable market access challenges. We know the NHS needs to do more with less, this is perhaps felt most acutely in the management of long-term conditions. The sheer number of people, increasing prevalence and an aging … Continued
The articulation of value in this high priority specialised disease has been a game changer. Accession worked closely with our client on a three-year launch programme to elicit and communicate the value of their therapeutic advancement to NHS England. Our programme commenced with education of the market and cross pollination of ideas and needs between senior clinical … Continued
Get in touch